FDA Issues New Anemia Drug Warnings
The U.S. Food and Drug Administration has revised the product labeling for a class of biotech drugs used to treat anemia, dealing a blow to drug maker Amgen....To view the full article, register now.
Already a subscriber? Click here to view full article